Kenneth P. Yale - 11 May 2022 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Kenneth P. Yale
Issuer symbol
BIOL
Transactions as of
11 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 13:35:41 UTC
Previous filing
03 May 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +40,927 $0.000000 40,927 11 May 2022 Common Stock 40,927 Direct F1, F2
transaction BIOL Restricted Stock Award $0 +3,200 +7.8% $0.000000 44,127 11 May 2022 Common Stock 3,200 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award fully vests and is immediately exercisable upon the one year anniversary of the date of grant.
F3 The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.